IVBIY and TAK Related Headlines
Go Back- Innovent Biologics closes $11.4 billion partnership with Takeda
- Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
- Innovent Biologics partners with Takeda in $11.4 billion cancer drug deal
- Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market
IVBIY and TAK Related Press Releases
Go Back- Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
- Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market
